Format

Send to

Choose Destination
See comment in PubMed Commons below
J Renin Angiotensin Aldosterone Syst. 2014 Dec;15(4):319-28. doi: 10.1177/1470320312474854. Epub 2013 Feb 5.

Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems.

Author information

1
Inserm U955, Maisons-Alfort, France, and Faculté de Médecine de Créteil, Université Paris-Est, France jin-bo.su@inserm.fr.

Abstract

Targeting the renin-angiotensin system (RAS) constitutes a major advance in the treatment of cardiovascular diseases. Evidence indicates that angiotensin-converting enzyme inhibitors and angiotensin AT1 receptor blockers act on both the RAS and the kallikrein-kinin system (KKS). In addition to the interaction between the RAS and KKS at the level of angiotensin-converting enzyme catalyzing both angiotensin II generation and bradykinin degradation, the RAS and KKS also interact at other levels: 1) prolylcarboxypeptidase, an angiotensin II inactivating enzyme and a prekallikrein activator; 2) kallikrein, a kinin-generating and prorenin-activating enzyme; 3) angiotensin-(1-7) exerts kininlike effects and potentiates the effects of bradykinin; and 4) the angiotensin AT1 receptor forms heterodimers with the bradykinin B2 receptor. Moreover, angiotensin II enhances B1 and B2 receptor expression via transcriptional mechanisms. These cross-talks explain why both the RAS and KKS are up-regulated in some circumstances, whereas in other circumstances both systems change in the opposite manner, expressed as an activated RAS and a depressed KKS. As the cross-talks between the RAS and the KKS play an important role in response to different stimuli, taking these cross-talks between the two systems into account may help in the development of drugs targeting the two systems.

KEYWORDS:

AT1/B2 heterodimers; Angiotensin AT1 receptor blocker; angiotensin-converting enzyme inhibitor; cardiovascular disease; the kallikrein–kinin system; the renin–angiotensin system; transcriptional regulation

PMID:
23386283
DOI:
10.1177/1470320312474854
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center